Delivery Order SPE2DX22D0049-SPE2D824FA2PU

Award Date 7/8/24
Potential Completion Date 7/8/24
Potential Value $12K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $156,131.50, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $1,138.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award, valued at $11,193.44, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order contract is for a full and open competition (no set-aside) to provide pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,714.71 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award, valued at $1,974.84, was issued by the Medical Supply Chain division of the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $10,961.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is for a Firm Fixed Price Delivery Order contract to provide pharmaceutical and medical supplies. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $13,866.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,755.20, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award, valued at $1,282.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the...
This federal contract award, valued at $2,574.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
  • SPE2DX22D0049
    Indefinite Delivery Contract
  • SPE2DX22D0049-SPE2D824FA2PU
    Delivery Order

This federal contract award, valued at $11,616.35, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order with a firm fixed price and no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the Department of Defense's military treatment programs and facilities globally. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/7/24, 10:56 AM